Exact Mass: 378.0747
Exact Mass Matches: 378.0747
Found 63 metabolites which its exact mass value is equals to given mass value 378.0747,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-Methylguanosine 5'-phosphate
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-hydroxy-2-imino-7-methyl-3,9-dihydro-2H-purin-7-ium
7-methylguanosine 5-phosphate is part of the RNA degradation pathway. It is a substrate for: m7GpppX diphosphatase, and m7GpppX diphosphatase.
Enterolactone 3'-sulfate
(3-{[(3S,4S)-4-[(3-hydroxyphenyl)methyl]-2-oxooxolan-3-yl]methyl}phenyl)oxidanesulphonic acid
Enterolactone 3'-sulfate
(3-{[(3S,4S)-4-[(3-hydroxyphenyl)methyl]-5-oxooxolan-3-yl]methyl}phenyl)oxidanesulphonic acid
Anastatin A
(2S) -2,3-Dihydro-5,7,8-trihydroxy-2- (4-hydroxyphenyl) -4H-Benzofuro [ 3,2-g ] -1-benzopyran-4-one
anastatin B
(2S)-2,3-Dihydro-5,9,10-trihydroxy-2-(4-hydroxyphenyl)-4H-benzofuro[2,3-h]-1-benzopyran-4-one
jusmicranthin methyl ester|jusmicranthin methyl ether
jusmicranthin methyl ester|jusmicranthin methyl ether
5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride
5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride
7-methylguanosine 5'-phosphate
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-hydroxy-2-imino-7-methyl-3,9-dihydro-2H-purin-7-ium
N-(2,5-difluorophenyl)-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide
N-(2,5-difluorophenyl)-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide
N-(2,5-difluorophenyl)-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
N-(2,5-difluorophenyl)-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
Thiazolidine, 3-[(4-methyl-3-nitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 3-[(4-methyl-3-nitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Vortioxetine hydrobromide
Vortioxetine (Lu AA21004) HBr
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Vortioxetine hydrobromide is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
(3,5-bis(trifluoromethyl)phenyl)(3,4-dimethoxyphenyl)methanone
(3,5-bis(trifluoromethyl)phenyl)(3,4-dimethoxyphenyl)methanone
2-[[3-(4-Methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetic acid ethyl ester
2-[[3-(4-Methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetic acid ethyl ester
N-({3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-YL}methyl)-D-glutamic acid
N-({3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-YL}methyl)-D-glutamic acid
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-tert-butylsulfonylprop-2-enenitrile
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-tert-butylsulfonylprop-2-enenitrile
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide
5-fluoro-3-[(4-methoxyphenyl)sulfonylamino]-1H-indole-2-carboxylic acid methyl ester
5-fluoro-3-[(4-methoxyphenyl)sulfonylamino]-1H-indole-2-carboxylic acid methyl ester
N-[[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)anilino]-sulfanylidenemethyl]-2-furancarboxamide
N-[[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)anilino]-sulfanylidenemethyl]-2-furancarboxamide
4-[(E)-[4-(furan-2-yl)-2-pyridin-3-ylimino-1,3-thiazol-3-yl]iminomethyl]benzene-1,3-diol
4-[(E)-[4-(furan-2-yl)-2-pyridin-3-ylimino-1,3-thiazol-3-yl]iminomethyl]benzene-1,3-diol
10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one
10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one
8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one
8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one
8,14,15-trihydroxy-4-(4-hydroxyphenyl)-3,11-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁷]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-6-one
8,14,15-trihydroxy-4-(4-hydroxyphenyl)-3,11-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁷]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-6-one
methyl (2r)-2,4-dihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
methyl (2r)-2,4-dihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
16-(2h-1,3-benzodioxol-5-yl)-14-methoxy-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-12-one
16-(2h-1,3-benzodioxol-5-yl)-14-methoxy-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-12-one
8-bromo-7-hydroxy-1-isopropyl-3a,9-dimethyl-1h,2h,3h,4h,10bh-benzo[e]azulene-5,6-dione
8-bromo-7-hydroxy-1-isopropyl-3a,9-dimethyl-1h,2h,3h,4h,10bh-benzo[e]azulene-5,6-dione
2-(3,4-dihydroxyphenyl)-6-[2-(3,4-dihydroxyphenyl)ethenyl]furo[3,2-c]pyran-4-one
2-(3,4-dihydroxyphenyl)-6-[2-(3,4-dihydroxyphenyl)ethenyl]furo[3,2-c]pyran-4-one
methyl 2,4-dihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
methyl 2,4-dihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
2-(3,4-dihydroxyphenyl)-6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]furo[3,2-c]pyran-4-one
2-(3,4-dihydroxyphenyl)-6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]furo[3,2-c]pyran-4-one
(5r)-5-[(6-bromo-1h-indol-3-yl)methyl]-5-ethoxy-2-imino-1,3-dimethylimidazolidin-4-one
(5r)-5-[(6-bromo-1h-indol-3-yl)methyl]-5-ethoxy-2-imino-1,3-dimethylimidazolidin-4-one
9,13,14-trihydroxy-5-(4-hydroxyphenyl)-4,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),2,8,11(16),12,14-hexaen-7-one
9,13,14-trihydroxy-5-(4-hydroxyphenyl)-4,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),2,8,11(16),12,14-hexaen-7-one
6,9,10,14,19-pentahydroxy-4,9-dimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),3,5,7,10,13,15,17-octaene-2,12-dione
6,9,10,14,19-pentahydroxy-4,9-dimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),3,5,7,10,13,15,17-octaene-2,12-dione
(4s)-8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one
(4s)-8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one
16-(2h-1,3-benzodioxol-5-yl)-10-methoxy-4,6,12-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-14-one
16-(2h-1,3-benzodioxol-5-yl)-10-methoxy-4,6,12-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-14-one
(14s)-16-(2h-1,3-benzodioxol-5-yl)-14-methoxy-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-12-one
(14s)-16-(2h-1,3-benzodioxol-5-yl)-14-methoxy-3,5,13-trioxatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,10,15-pentaen-12-one
(1r,3as,10bs)-8-bromo-7-hydroxy-1-isopropyl-3a,9-dimethyl-1h,2h,3h,4h,10bh-benzo[e]azulene-5,6-dione
(1r,3as,10bs)-8-bromo-7-hydroxy-1-isopropyl-3a,9-dimethyl-1h,2h,3h,4h,10bh-benzo[e]azulene-5,6-dione
